MX9203219A - Compuestos novedosos de morfolinol, su preparacion y empleo. - Google Patents

Compuestos novedosos de morfolinol, su preparacion y empleo.

Info

Publication number
MX9203219A
MX9203219A MX9203219A MX9203219A MX9203219A MX 9203219 A MX9203219 A MX 9203219A MX 9203219 A MX9203219 A MX 9203219A MX 9203219 A MX9203219 A MX 9203219A MX 9203219 A MX9203219 A MX 9203219A
Authority
MX
Mexico
Prior art keywords
compounds
morfolinol
novelty
preparation
carbon atoms
Prior art date
Application number
MX9203219A
Other languages
English (en)
Inventor
James Leroy Kelley
David Lee Musso
Grady Evan Boswell
Barrett Randolph Cooper
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MX9203219A publication Critical patent/MX9203219A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9203219A 1989-10-31 1992-06-24 Compuestos novedosos de morfolinol, su preparacion y empleo. MX9203219A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898924528A GB8924528D0 (en) 1989-10-31 1989-10-31 Heterocyclic pharmaceutical compounds,preparation and use

Publications (1)

Publication Number Publication Date
MX9203219A true MX9203219A (es) 1992-07-01

Family

ID=10665482

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203219A MX9203219A (es) 1989-10-31 1992-06-24 Compuestos novedosos de morfolinol, su preparacion y empleo.

Country Status (19)

Country Link
US (1) US5104870A (es)
EP (1) EP0426416B1 (es)
JP (1) JP2873076B2 (es)
AT (1) ATE101604T1 (es)
AU (1) AU645763B2 (es)
CA (1) CA2028893C (es)
DE (1) DE69006682T2 (es)
DK (1) DK0426416T3 (es)
ES (1) ES2062406T3 (es)
FI (1) FI94753C (es)
GB (1) GB8924528D0 (es)
HU (2) HU207304B (es)
IE (1) IE66115B1 (es)
LV (1) LV11030B (es)
MX (1) MX9203219A (es)
NZ (1) NZ235882A (es)
PT (1) PT95735B (es)
SG (1) SG28347G (es)
ZA (1) ZA908696B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
AU1403899A (en) * 1997-11-14 1999-06-07 Glaxo Group Limited Method of treating addiction to nicotine products
MA26693A1 (fr) * 1998-09-28 2004-12-20 Glaxo Group Ltd Compositions pour administration par voie buccale
AU7750100A (en) * 1999-10-13 2001-04-23 Glaxo Group Limited Method for the treatment of obesity
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
US7763612B2 (en) * 2006-01-03 2010-07-27 Algebra, Inc. Therapeutic amine-arylsulfonamide conjugate compounds
AU2010236404B2 (en) 2009-04-15 2016-11-03 Research Triangle Institute Monoamine reuptake inhibitors
AU2011255276B2 (en) 2010-05-21 2016-09-22 Research Triangle Institute Phenylmorpholines and analogues thereof
AU2011255456B2 (en) * 2010-05-21 2017-01-19 Dignity Health Doing Business As St. Joseph's Hospital And Medical Center And Barrow Neurological Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
CN105949142B (zh) * 2016-05-21 2018-03-27 南华大学 具有抗抑郁活性的单一手性化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8417170D0 (en) * 1984-07-05 1984-08-08 Wellcome Found Heterocyclic pharmaceutical compounds

Also Published As

Publication number Publication date
PT95735B (pt) 1998-01-30
EP0426416A1 (en) 1991-05-08
DE69006682T2 (de) 1994-08-04
DE69006682D1 (de) 1994-03-24
HU906935D0 (en) 1991-05-28
LV11030B (en) 1996-08-20
ATE101604T1 (de) 1994-03-15
ES2062406T3 (es) 1994-12-16
LV11030A (lv) 1996-02-20
FI905356A0 (fi) 1990-10-30
PT95735A (pt) 1991-09-13
JPH03206084A (ja) 1991-09-09
FI94753C (fi) 1995-10-25
CA2028893A1 (en) 1991-05-01
CA2028893C (en) 2000-10-10
AU6563990A (en) 1991-05-09
AU645763B2 (en) 1994-01-27
SG28347G (en) 1995-09-18
IE66115B1 (en) 1995-12-13
US5104870A (en) 1992-04-14
HU211304A9 (en) 1995-11-28
DK0426416T3 (da) 1994-03-14
JP2873076B2 (ja) 1999-03-24
IE903888A1 (en) 1991-05-08
HU207304B (en) 1993-03-29
NZ235882A (en) 1993-05-26
FI94753B (fi) 1995-07-14
ZA908696B (en) 1992-07-29
GB8924528D0 (en) 1989-12-20
HUT57748A (en) 1991-12-30
EP0426416B1 (en) 1994-02-16

Similar Documents

Publication Publication Date Title
ATE85608T1 (de) Verbindungen mit biologischer aktivitaet.
ES2071681T3 (es) Compuestos macrociclicos.
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
HK1007143A1 (en) Benzoxazine compounds and pharmaceutical use thereof
FI932445A0 (fi) Farmaceutiska foereningar
MX9203219A (es) Compuestos novedosos de morfolinol, su preparacion y empleo.
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
DE68919378D1 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
CA2108967A1 (en) Arylmorpholine, preparation and use
DE3775666D1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
KR880007070A (ko) 백내장 치료용 약학 조성물
DE3768516D1 (de) Chinonamide, deren herstellung und anwendung.
HUT49283A (en) Process for production of medical compositions applicable for treatment of peptical ulcer
KR910021244A (ko) 당뇨병성 괴저 치료제
TH50173A (th) การใช้ 1-ไฮดรอกซี-2-ไพริโดนสำหรับการบำบัดการติดเชื้อที่ผิวหนัง
KR890001549A (ko) 위염 치료제